Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Polymeric Biomaterials Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The polymeric biomaterials market size has experienced significant expansion in recent years. It is projected to increase from $69.32 billion in 2025 to $81 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.8%. The historical growth in this market can be attributed to factors such as medical implant demand, an increase in surgical procedures, advancements in polymer science, the expansion of hospital infrastructure, and the adoption of healthcare technology.
The polymeric biomaterials market is anticipated to observe significant expansion in the coming years. This market is projected to achieve a size of $141.61 billion by 2030, growing at a compound annual growth rate (CAGR) of 15.0%. The expansion during this forecast period is attributed to aging population healthcare needs, regenerative medicine growth, minimally invasive surgeries, personalized medicine development, and biodegradable polymer innovation. Prominent trends expected in this period encompass rising adoption in tissue engineering, increasing use in drug delivery systems, expansion of biodegradable implant materials, growing demand for advanced surgical polymers, and a focus on personalized medical biomaterials.
Get A Free Sample Report With In-Depth Market Insights:
Polymeric Biomaterials Market Growth Drivers: What’s Behind The Acceleration?
The expanding occurrence of chronic diseases is anticipated to fuel the growth of the polymeric biomaterials market. These conditions are long-lasting, typically advancing slowly and persisting throughout an individual’s life. Their increasing prevalence stems from factors such as an aging population, lifestyle choices, economic burden, healthcare demand, and public health challenges. Polymeric biomaterials play a crucial role in addressing chronic diseases by providing innovative solutions that improve treatment efficacy and enhance the quality of life for those affected. They are also integral to the creation of various medical devices and implants like stents, catheters, and joint replacements, vital for managing chronic conditions necessitating surgical intervention. For example, the World Health Organization (WHO) reported in September 2023 that 41 million deaths occur globally each year, making up 74% of all fatalities due to chronic diseases. This figure encompasses 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the rising incidence of chronic diseases is a key driver for the polymeric biomaterials market.
Polymeric Biomaterials Market Segment Analysis: What Are The Core Market Categories?
The polymeric biomaterials market covered in this report is segmented –
1) By Product: Polylactic Acid, Polyglycolic Acid, Polyurethanes, Polytetrafluoroethylene, Polyaryletherketone, Polydioxanone, Other Products
2) By Application: Cardiovascular, Dental, Orthopedic, Plastic Surgery, Other Applications
3) By End-User: Hospitals, Clinics, Other End-users
Subsegments:
1) By Polylactic Acid (PLA): PLA-Based Scaffolds, PLA-Based Sutures And Stents
2) By Polyglycolic Acid (PGA): PGA-Based Sutures, PGA-Based Scaffolds
3) By Polyurethanes: Polyurethane-Based Wound Dressings, Polyurethane-Based Implants
4) By Polytetrafluoroethylene (PTFE): PTFE-Based Vascular Grafts, PTFE-Based Membranes
5) By Polyaryletherketone (PAEK): PAEK-Based Implants, PAEK-Based Prosthetics
6) By Polydioxanone (PDO): PDO-Based Sutures, PDO-Based Drug Delivery Systems
7) By Other Products: Biodegradable Polymers, Natural Polymers
Polymeric Biomaterials Market Trends: What’s Defining The Industry’s Next Phase?
Major companies in the polymeric biomaterials market are focusing on developing advanced innovations, such as reinforced PEEK 3D printing filaments, to gain a competitive advantage. These reinforced PEEK 3D printing filaments are high-performance polymer biomaterials enhanced with carbon fiber, enabling extrusion-based 3D printing of custom medical implants with superior strength, biocompatibility, and a metal-free design. For instance, in October 2023, Evonik Industries AG, a Germany-based specialty chemicals company, introduced VESTAKEEP iC4620 3DF (and its 12% carbon fiber counterpart, VESTAKEEP iC4612 3DF). These filaments offer a high strength-to-weight ratio, control over fiber alignment during printing for optimized mechanical properties, and full biocompatibility for long-term body-contact medical implants. These material innovations support the shift toward patient-specific, 3D-printed implants that rival traditional metal devices, though manufacturers must manage process complexity and ensure quality control for consistent mechanical properties.
Polymeric Biomaterials Market Top Companies Driving Competitive Growth
Major companies operating in the polymeric biomaterials market are BASF SE, 3M Company, Medtronic plc, Toray Industries Inc., Evonik Industries AG, Covestro AG, Stryker Corporation, Solvay SA, DuPont Biomaterials, Arkema Group, Mitsubishi Chemical Holdings Inc., Celanese Corporation, Royal DSM, TEIJIN Limited, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., W. L. Gore & Associates Inc., Corbion NV, Integra LifeSciences Holdings Corporation, Victrex plc, Collagen Matrix, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Covation Biomaterials, Starch Medical Inc.
View The Full Polymeric Biomaterials Market Report:
Polymeric Biomaterials Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the polymeric biomaterials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymeric biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
